JP2024503000A5 - - Google Patents

Info

Publication number
JP2024503000A5
JP2024503000A5 JP2023541286A JP2023541286A JP2024503000A5 JP 2024503000 A5 JP2024503000 A5 JP 2024503000A5 JP 2023541286 A JP2023541286 A JP 2023541286A JP 2023541286 A JP2023541286 A JP 2023541286A JP 2024503000 A5 JP2024503000 A5 JP 2024503000A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
sequence
seq
isolated polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503000A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011841 external-priority patent/WO2022150712A1/en
Publication of JP2024503000A publication Critical patent/JP2024503000A/ja
Publication of JP2024503000A5 publication Critical patent/JP2024503000A5/ja
Pending legal-status Critical Current

Links

JP2023541286A 2021-01-08 2022-01-10 発現構築物およびその使用 Pending JP2024503000A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163135501P 2021-01-08 2021-01-08
US63/135,501 2021-01-08
PCT/US2022/011841 WO2022150712A1 (en) 2021-01-08 2022-01-10 Expression constructs and uses thereof

Publications (2)

Publication Number Publication Date
JP2024503000A JP2024503000A (ja) 2024-01-24
JP2024503000A5 true JP2024503000A5 (https=) 2025-01-20

Family

ID=80222240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541286A Pending JP2024503000A (ja) 2021-01-08 2022-01-10 発現構築物およびその使用

Country Status (13)

Country Link
US (1) US20240166707A1 (https=)
EP (1) EP4274846A1 (https=)
JP (1) JP2024503000A (https=)
KR (1) KR20230129479A (https=)
CN (1) CN116917309A (https=)
AR (1) AR124599A1 (https=)
AU (1) AU2022205679A1 (https=)
CA (1) CA3204373A1 (https=)
CO (1) CO2023009063A2 (https=)
IL (1) IL304118A (https=)
MX (1) MX2023008002A (https=)
TW (1) TW202241931A (https=)
WO (1) WO2022150712A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120548367A (zh) 2022-11-18 2025-08-26 波士顿大学董事会 自复制rna及其用途
AU2024299882A1 (en) 2023-07-25 2026-01-08 Strand Therapeutics Inc. Polynucleotides comprising a micro rna detargeting sensor and uses thereof
WO2025076415A1 (en) * 2023-10-06 2025-04-10 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Inducible transgenes encoding intracellular molecules for modulating immune cell function

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
CA1327358C (en) 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2309535A1 (en) 1997-11-12 1999-05-20 Brigham And Women's Hospital, Inc. The translation enhancer element of the human amyloid precursor protein gene
CA2398790A1 (en) 2000-01-28 2001-08-02 The Scripps Research Institute Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
US7468275B2 (en) 2000-01-28 2008-12-23 The Scripps Research Institute Synthetic internal ribosome entry sites and methods of identifying same
EP2447370B1 (en) 2001-09-28 2018-07-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MicroRNA molecules
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
ES2333724T3 (es) 2003-09-26 2010-02-26 Merck Serono Sa Secuencias lideres para uso en la produccion de proteinas.
EP2479254A1 (en) 2005-08-24 2012-07-25 The Scripps Research Institute Translation enhancer-element dependent vector systems
US7670840B2 (en) 2006-01-05 2010-03-02 The Ohio State University Research Foundation Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors
EP1969147B1 (en) 2006-01-05 2014-07-30 The Ohio State University Research Foundation microRNA-based methods for the diagnosis of stomach cancer
EP2522746B1 (en) 2006-03-02 2014-11-12 The Ohio State University Research Foundation MicroRNA expression profile associated with pancreatic cancer
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
US8252538B2 (en) 2006-11-01 2012-08-28 The Ohio State University MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma
WO2008073915A2 (en) 2006-12-08 2008-06-19 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
WO2008147974A1 (en) 2007-05-23 2008-12-04 University Of South Florida Micro-rnas modulating immunity and inflammation
US20090099034A1 (en) 2007-06-07 2009-04-16 Wisconsin Alumni Research Foundation Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
CN101918594A (zh) 2007-11-30 2010-12-15 俄亥俄州立大学研究基金会 肺癌中外周血中的微rna表达特征谱和靶向
SG10201408162PA (en) 2007-12-11 2015-01-29 Scripps Research Inst Compositions and methods related to mrna translational enhancer elements
EP2260110B1 (en) 2008-02-08 2014-11-12 Asuragen, INC. miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
CA2717026A1 (en) 2008-02-28 2009-09-03 The Ohio State University Research Foundation Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof
EP2112235A1 (en) 2008-04-24 2009-10-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
PL215513B1 (pl) 2008-06-06 2013-12-31 Univ Warszawski Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
WO2010018563A2 (en) 2008-08-12 2010-02-18 Rosetta Genomics Ltd. Compositions and methods for the prognosis of lymphoma
US9074206B2 (en) 2008-11-13 2015-07-07 Fudan University Compositions and methods for micro-RNA expression profiling of colorectal cancer
EP2358902A1 (en) 2008-12-10 2011-08-24 Universität Regensburg Compositions and methods for micro-rna expression profiling of cancer stem cells
EP2427574A2 (en) 2009-05-08 2012-03-14 The Ohio State University Research Foundation Microrna expression profiling and targeting in chronic obstructive pulmonary disease (copd) lung tissue and methods of use thereof
WO2011076143A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expression profiling of lung cancer
WO2011076142A1 (en) 2009-12-24 2011-06-30 Fudan University Compositions and methods for microrna expession profiling in plasma of colorectal cancer
EP2341145A1 (en) 2009-12-30 2011-07-06 febit holding GmbH miRNA fingerprint in the diagnosis of diseases
WO2011094683A2 (en) 2010-01-29 2011-08-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Method of identifying myelodysplastic syndromes
EP2354246A1 (en) 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
US20130059015A1 (en) 2010-03-11 2013-03-07 H. Lee Moffitt Cancer Center & Research Institute Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
WO2011157294A1 (en) 2010-06-16 2011-12-22 Universita' Degli Studi Di Padova Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
US20130230884A1 (en) 2010-07-16 2013-09-05 John Chaput Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
WO2012151212A1 (en) 2011-05-01 2012-11-08 University Of Rochester Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
EP2705370A2 (en) 2011-05-06 2014-03-12 Xentech Markers for cancer prognosis and therapy and methods of use
DK2732052T3 (en) 2011-07-15 2017-02-20 Leo Pharma As Diagnostic microRNA profiling in cutaneous T cell lymphoma (CTCL)
EP2751292A4 (en) 2011-09-01 2015-05-20 Allegro Diagnostics Corp METHOD AND COMPOSITIONS FOR DETECTING CANCER BASED ON MIRNA EXPRESSION PROFILES
EP2758436B1 (en) 2011-09-23 2019-06-12 Universität Stuttgart Serum half-life extension using immunoglobulin binding domains
US20140243240A1 (en) 2011-10-26 2014-08-28 Georgetown University microRNA EXPRESSION PROFILING OF THYROID CANCER
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
EP3053585A1 (en) 2013-12-13 2016-08-10 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
WO2015196118A1 (en) 2014-06-19 2015-12-23 Moderna Therapeutics, Inc. Alternative nucleic acid molecules and uses thereof
CN108064176A (zh) * 2015-04-22 2018-05-22 库瑞瓦格股份公司 用于治疗肿瘤疾病的含有rna的组合物
SI3458083T1 (sl) 2016-05-18 2023-03-31 Modernatx, Inc. Polinukleotidi, ki kodirajo interlevkin-12 (IL12) in njihova uporaba
CN109715205A (zh) * 2016-08-19 2019-05-03 库瑞瓦格股份公司 用于癌症治疗的rna
TW202428301A (zh) 2017-02-28 2024-07-16 法商賽諾菲公司 治療性rna
JP7285220B2 (ja) * 2017-05-18 2023-06-01 モデルナティエックス インコーポレイテッド 連結したインターロイキン-12(il12)ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
WO2020123716A1 (en) * 2018-12-11 2020-06-18 Obsidian Therapeutics, Inc. Membrane bound il12 compositions and methods for tunable regulation

Similar Documents

Publication Publication Date Title
JP2024503000A5 (https=)
Li et al. mRNA vaccine in cancer therapy: Current advance and future outlook
Liu et al. mRNA cancer vaccines: construction and boosting strategies
JP2023535225A5 (https=)
ES2922760T3 (es) Vacunas de virus respiratorios
Fu et al. mRNA vaccines in the context of cancer treatment: from concept to application
AU2016286364B2 (en) ATP-binding cassette family coding polyribonucleotides and formulations thereof
CA3198311A1 (en) Compositions and methods for stabilization of lipid nanoparticle mrna vaccines
EP3315608A1 (en) Sirna, pharmaceutical composition and conjugate which contain sirna, and uses thereof
JP2022524391A5 (https=)
JP2024528447A (ja) 非天然型5’非翻訳領域及び3’非翻訳領域、及びその用途
JP2022174191A (ja) Rnaの投与のための配合物
WO2017081110A1 (en) Rotavirus vaccines
JP7808695B2 (ja) タンパク質発現のためのmRNA及びそのための鋳型
JP2023523414A5 (https=)
ES2919552T3 (es) Procedimientos de utilización de polinucleotidos codificadores de ligando ox40
JP2020072720A (ja) Vlp−レプリコンを用いたクラスii mhc抗原の送達による癌免疫療法
JP2003525222A (ja) Il−12をコードする核酸分子の腫瘍内投与
Copur Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
DeFranciscis et al. Clinical applications of oligonucleotides for cancer therapy
JP2024503000A (ja) 発現構築物およびその使用
Dixit et al. Functionalised ligand-based nanomaterial drug targeting approaches for colorectal cancer therapy
Galant et al. mRNA vaccines in the treatment of cancer
JP2024542126A5 (https=)
JP2011500011A (ja) 癌治療用の組合せ製品